Literature DB >> 10197625

A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression.

M Ogawa1, K Umehara, W G Yu, Y Uekusa, C Nakajima, T Tsujimura, T Kubo, H Fujiwara, T Hamaoka.   

Abstract

Interleukin (IL) 12 has been shown to elicit tumor regression when this cytokine induces the migration of T cells to tumor sites. The present study investigates the role of a peritumoral stromal reaction in IL-12-induced T-cell migration. In the CSA1M and OV-HM tumor models, IL-12 treatment induced tumor regression that is associated with T-cell migration. Neither T-cell migration nor tumor regression was observed in the Meth A and MCH-1-A1 models. Stromal tissue containing neovascular blood vessels developed at the peritumoral area of the former two IL-12-responsive tumors but not at the peritumoral area of the latter two IL-12-unresponsive tumors. The significance of stroma development was investigated using a pair of tumor models (CSA1M and a subline derived from CSA1M designated the CSA1M variant), both of which exhibit the same tumor immunogenicity. In contrast to the parental CSA1M cell line, the variant cell line was not responsive to IL-12, and neither stroma development nor T-cell migration was observed, even after IL-12 treatment. Histological analyses revealed that the parental cell line had peritumoral stroma with intrastromal vessels but only a few vessels in tumor parenchyma, whereas the variant cell line showed no stroma but had abundant vasculature in the tumor parenchyma. Most importantly, only stromal vessels in the parental tumors expressed detectable and enhanced levels of vascular cell adhesion molecule 1 (VCAM-1)/ intercellular adhesion molecule 1 (ICAM-1) before and after IL-12 treatment, respectively. In contrast, parenchymal vasculature in the variant cell line failed to express VCAM-1/ICAM-1 even after IL-12 treatment. When transferred into recipient tumor-bearing mice, IL-12-stimulated T cells from the parental CSA1M-bearing or the variant CSA1M-bearing mice migrated into the parental but not into the variant tumor mass. Together with our previous finding that T-cell migration depends on the VCAM-1/ICAM-1 adhesive interactions, the present results indicate a critical role for peritumoral stroma/stromal vasculature in the acceptance of tumor-infiltrating T cells that is a prerequisite for IL-12-induced tumor regression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197625

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  IL-12 as well as IL-2 upregulates CCR5 expression on T cell receptor-triggered human CD4+ and CD8+ T cells.

Authors:  Y F Yang; M Tomura; M Iwasaki; T Mukai; P Gao; S Ono; J P Zou; G M Shearer; H Fujiwara; T Hamaoka
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

2.  CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes.

Authors:  Hui Huang; Siguo Hao; Fang Li; Zhenmin Ye; Junbao Yang; Jim Xiang
Journal:  Immunology       Date:  2007-02       Impact factor: 7.397

3.  Mycobacterial infection inhibits established allergic inflammatory responses via alteration of cytokine production and vascular cell adhesion molecule-1 expression.

Authors:  Xi Yang; Yijun Fan; Shuhe Wang; Xiaobing Han; Jie Yang; Laura Bilenki; Lijun Chen
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

4.  The clinical significance of massive intratumoral lymphocytosis in squamous cell carcinoma of the anus.

Authors:  Carlos A Rubio; Per J Nilsson; Fredrik Petersson; Ander Höög; Harald Blegen; Runjan Chetty
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors.

Authors:  Kotaro Sasaki; Angela D Pardee; Yanyan Qu; Xi Zhao; Ryo Ueda; Gary Kohanbash; Lisa M Bailey; Hideho Okada; Ravikumar Muthuswamy; Pawel Kalinski; Per H Basse; Louis D Falo; Walter J Storkus
Journal:  J Immunother       Date:  2009-10       Impact factor: 4.456

6.  Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion.

Authors:  Ashlyn J Bernier; Jing Zhang; Erik Lillehoj; Andrew R E Shaw; Nirosha Gunasekara; Judith C Hugh
Journal:  Mol Cancer       Date:  2011-07-28       Impact factor: 27.401

7.  Oncolytic activity of HF10 in head and neck squamous cell carcinomas.

Authors:  Shinichi Esaki; Fumi Goshima; Haruka Ozaki; Gaku Takano; Yoshimi Hatano; Daisuke Kawakita; Kei Ijichi; Takahiro Watanabe; Yoshitaka Sato; Takayuki Murata; Hiromitsu Iwata; Yuta Shibamoto; Shingo Murakami; Yukihiro Nishiyama; Hiroshi Kimura
Journal:  Cancer Gene Ther       Date:  2019-09-03       Impact factor: 5.987

8.  Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells.

Authors:  Eun-Jung Lee; Seo Jin Lee; Ji-Hye Kim; Kyoung-Jin Kim; Seung-Hyun Yang; Keun-Yeong Jeong; Jinsil Seong
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.